Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer

Molecular Endocrinology

Volumn 16, Issue 3, 2002, Pages 487-496

  Weatherman, R V ^a   Chang, C Y ^b   Clegg, N J ^a   Carroll, D C ^c   Day, R N ^d   Baxter, J D ^a   McDonnell, D P ^e   Scanlan, T S ^a   Schaufele, F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIHYDROXYFLAVONE; AMINO ACID; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; ETHYL INDENESTROL A; FLAVONE DERIVATIVE; FULVESTRANT; GREEN FLUORESCENT PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; DRUG STRUCTURE; ENERGY TRANSFER; FLUORESCENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MOLECULAR INTERACTION; MUTATION; PRIORITY JOURNAL;

EID: 0036185483     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.3.0813     Document Type: Article

References (54)

1. Control of transcription activation by steroid hormone receptors
2. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
3. From ligand to response: Generating diversity in nuclear receptor coregulator function
4. Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures
5. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer
6. Tamoxifen, raloxifene, and the prevention of breast cancer
7. Tamoxifen in the treatment of breast cancer
8. Estrogen/hormone replacement therapy and the etiology of breast cancer
9. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women
10. Risks and benefits of tamoxifen therapy
11. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation
12. Therapeutic potential of selective estrogen receptor modulators
13. Therapeutic potential of selective modulators of nuclear receptor action
14. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
15. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions
16. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
17. Molecular basis of agonism and antagonism in the oestrogen receptor
18. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
19. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
20. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β
21. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors α and β
22. Peptide antagonists of the human estrogen receptor
23. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
24. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
25. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
26. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer
27. The green fluorescent protein
28. Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleus
29. Calibration of gluorescence resonance energy transfer in microscopy using genetically engineered GFP derivatives on nickel chelating beads
30. Resonance energy transfer microscopy
31. Temporally distinct and ligand-specific recruitment of nuclear receptor interacting peptides and co-factors to subnuclear domains containing the estrogen receptor
32. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
33. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity
34. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins
35. Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy
36. The limits of the cellular capacity to mediate an estrogen response
37. CCAAT/enhancer binding protein α assembles essential cooperating factors in common subnuclear domains
38. 2-Arylindenes and 2-arylindenones: Molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor
39. Estrogen receptor stereochemistry: Ligand binding and hormonal responsiveness
40. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens
41. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
42. Increasing the complexity of coactivation in nuclear receptor signaling
43. Co-activators and co-repressors in the integration of transcriptional responses
44. Coactivator and corepressor complexes in nuclear receptor function
45. Direct visualization of the human estrogen receptor α reveals a role for ligand in the nuclear distribution of the receptor
46. The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells
47. Subnuclear trafficking of estrogen receptor-a and steroid receptor coactivator-1
48. Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor α-coactivator complexes in living cells
49. Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription
50. Visualization of Pit-1 transcription factor interactions in the living cell nucleus by fluorescence resonance energy transfer microscopy
51. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor
52. Estrogen receptor pathways to AP-1
53. Selection of estrogen receptor β and thyroid hormone receptor β-specific co-activator-mimetic peptides using recombinant peptide libraries
54. Differential SERM activation of the estrogen receptors (ERα and ERβ) at AP-1 sites